John Brendan Doyle, Chief Financial Officer at COGNITION THERAPEUTICS INC (CGTX), bought 10,000 shares at $1.13 ($11K) on 2026-04-16, disclosed to the SEC on 2026-04-20.
CFO John Brendan Doyle purchased 10,000 shares at $1.13 on April 16, 2026, marking the largest insider purchase in the company's history. This rare reversal comes after five consecutive insider sales and suggests management confidence in the stock's recovery potential.
The stock is currently trading at $1.12, up 14.94% over the last five days despite a 20% decline over the past 90 days. The price remains significantly below the 52-week high of $3.83.
Clearly above the average filing.